StockData
TriSalus Life Sciences, Inc. logo

TriSalus Life Sciences, Inc. (TLSI) income statement

TLSINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as TLSIW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$2.17−0.28 (-11.22%)

Close on Nov 19, 2026Market cap $133.93MP/E –Yield –

TriSalus Life Sciences, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
85.8%
Operating margin
-67.7%
Net margin
-62.6%
Return on equity, FY2025
131.3%

Financial strength

Current ratio
5.35
Debt to equity
5.05
Debt to assets
52.9%
Cash to current liabilities
414.3%

Valuation

P/E ratio
–
Price to sales
2.97
Price to book
20.45
Dividend yield
–

See a number that looks wrong?